Pro_S2009
27 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Master Investor – 23 Jan 20 Circassia Pharmaceuticals – these shares could double over the next year -... Circassia shares have been in the doldrums for some time now, but brokers are expecting a turnaround in fortunes, writes Mark Watson-Mitchell. .
Pro_S2009
15 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 More of the Invesco overhang gone with more II buying : [link] .
Pro_S2009
14 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 This is Money – 13 Jan 20 SMALL CAP SHARE IDEAS: Circassia Pharmaceuticals one for the recovery A recent trading update highlighted good sales growth while cash - another key metric for any early-stage biotech - was healthier than expected.
Pro_S2009
10 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Nice to see. More of the Invesco overhang being cleared I assume. [link] .
Pro_S2009
10 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 NIOX sales in China were up nearly 200% at the interims, massive growth there. And the new version will also enhance more sales growth moving forward. NS Medical Devices – 3 Jan 20 Updated NIOX VERO device will make asthma diagnosis more efficient The NIOX VERO Plus features a larger, higher resolution screen, improved user interface and a carry handle for added mobility compared to its predecessor .
Pro_S2009
09 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Broker update (PDF file): Upload Files Upload files for free - CIR_9_JAN_2020 - Copy.pdf Upload files, for free, securely, anonymously, without limits. @UploadFilesFree .
Pro_S2009
09 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Comment from Finncap. Morning Note 9 January 2020 Circassia issued a positive trading update for the year to 31 December 2019, with revenues expected to be in the middle of its £60-65m guidance range and in line with our forecasts. Year-end cash was c.£11m higher than our expectations at £27m, due to working capital timing (delayed payment for Tudorza and Duaklir inventory and boosted by third-party rebates). Stripping out these timing effects, there was a modest H2 2019 cash outflow (we estimate to have been c.£5m), which nevertheless contrasts starkly with the £20m outflow in H1 and underpins our view that the business will be EBITDA positive in 2020. We reiterate our target price of 80p, which is supported by premium revenue growth (2-year CAGR of 30%), cash generation and deleveraging balance sheet .
Pro_S2009
09 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Excellent. Delivered as promised. [link] .
Pro_S2009
03 Jan 2020
Circassia Pharma - One to grow in 2020/21/22 Adams Increases Stake In Circassia Pharmaceuticals Fri, 3rd Jan 2020 09:50 Alliance News (Alliance News) - Adams PLC on Friday said it has raised its holding in Circassia Pharmaceuticals Ltd. Adams, which invests in AIM-listed companies, bought 2.4 million shares on Thursday at an average price of 19.0 pence per share for a total investment of GBP456,229. It brings its holdings in Circassia to 3.1 million shares, an 0.8% stake. Circassia shares were up 1.4% at 19.70p on Friday morning in London. The follow-on investment comes after Circassia early in December forecast revenue for 2019 to be between GBP60 million to GBP65 million compared to the GBP48.3 million in 2018. Following the purchase investment, Adams has a cash balance of around GBP1 million, it said. Shares in Adams were trading flat at 5.00p each on Friday morning in London.
Pro_S2009
18 Dec 2019
Circassia Pharma - One to grow in 2020/21/22 I found the write up quite compelling and Richard Griffiths is no mug and now the largest holder, certainly worth having some. in my view. The write up was from Finncap in September, PDF download link below: Upload Files Upload files for free - Circassia_SEP_2019.pdf Upload files, for free, securely, anonymously, without limits. @UploadFilesFree . Web site is [link] Currently some insti selling and others buying. Looks primed now for cash generation in 2020 and moving to profits in 2021. No need for any further fund raising. Products in Respiratory area, which is fast growing in some aspects of their business due to all the air pollution around now. Certainly a good idea for a share to hold for the coming couple of years, significant potential in my view.
Ripley94
30 Jun 2019
Limit buy yesterday CIR… XXXX Good by thursday it was 10% up next day . See above it was liked by LKHyman late November 2015 he was one of the best selectors on this site in note. Not posted for years hope hes well.
Ripley94
27 Jun 2019
Limit buy yesterday CIR… XXXXXX Two parts of order lifted by 3.30pm ( approx 60% ) @ 14.40p
Ripley94
08 Jun 2019
Limit buy yesterday CIR… XXXX Unlucky the limit did not lift on the Wednesday low , up well by Friday 7th . Woody needs funds has reduced from 28% to 24% i read .
Ripley94
04 Jun 2019
Limit buy yesterday CIR… XXXX 15 % fall back today went to 16p early so much for buying into rise as some say . That is over a 50% fall since April .
Ripley94
01 Apr 2019
Limit buy yesterday CIR… XXXX 20% rise today from lows . Maybe time to buy it ??
